© 2026 Buobe

Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease | Buobe

Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease

Published by

www.medpagetoday.com

on •1 min read

(MedPage Today) -- A 6-month tuberculosis (TB) treatment regimen delivered similar results to the longer standard-of-care regimen in patients with pulmonary rifampicin-resistant TB, a phase III noninferiority trial showed.